doi: 10.1161/CIRCRESAHA.109.195495
© 2009 American Heart Association, Inc.
Editorials |
Innate Short-Circuiting of Mitochondrial Metabolism in Cardiac Hypertrophy
Identification of Novel Consequences of Enhanced Anaplerosis
From the Translational Medicine Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Md.
Correspondence to Michael N. Sack, Building 10-CRC, Room 5-3150, 10 Center Dr, MSC 1454, Bethesda, MD 20892-1454. E-mail sackm@nhlbi.nih.gov
See related articles, pages 805–812
Key Words: malic enzyme • anaplerosis • cardiac hypertrophy • triacylglycerol
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Cardiac hypertrophy is a precursor to the development of heart failure and an independent clinical risk factor for sudden death and myocardial infarction.1 Although energetic deficits are associated with clinical heart failure, their relative contribution to the transition from cardiac hypertrophy to heart failure has been challenging to elucidate, in large part because of the unpredictability of the timing of this transition and limitations of studying human cardiac energetics in vivo. Nevertheless, our understating of this pathophysiology is being illuminated using experimental models.
In the normal heart, the oxidation of exogenous fats is the major fuel source, with additional significant contributions from glucose and lactate. The relative contribution of fats diminishes with enhanced reliance on glucose utilization during the development of cardiac hypertrophy. The regulatory programs attenuating fat utilization have been extensively investigated and include regulation at the transcriptional and posttranscriptional levels.2–5 Moreover, this reduction involves coordinate downregulation of proteins controlling fatty acid uptake by the heart and mitochondria as well as of the enzymes controlling mitochondrial fatty acid β-oxidation (FAO).2,6–9 The increased utilization of glucose is similarly regulated at multiple levels and interestingly, at least with robust hypertrophy, the coupling of glycolysis and pyruvate oxidation becomes disrupted with an insufficient increase in glucose oxidation to completely compensate for the reduced FAO.10,11 The mechanisms orchestrating this uncoupling have not been fully delineated, although do not appear to result from disruption in the pyruvate dehydrogenase complex activity.12 With advancing cardiac hypertrophy, perturbations in substrate partitioning and selection become associated with reduced
Related Article:
Circ. Res. 2009 104: 805-812.
This article has been cited by other articles:
 |
|
 |
|
  Z. Lu, I. Scott, B. R. Webster, and M. N. Sack The Emerging Characterization of Lysine Residue Deacetylation on the Modulation of Mitochondrial Function and Cardiovascular Biology Circ. Res., October 23, 2009; 105(9): 830 - 841. [Abstract] [Full Text] [PDF]
|
|